Professional Documents
Culture Documents
CHARACTERIZATION OF
4’-SUBSTITUTED SPIRANES
Orga
nic Organic
Water
synth solvents
esis
Solid
state
AIM AND SCOPE
Heterocyclic ring systems of spiro indoline pyrrolidine
nucleus
In
Inorder
ordertotoeliminate
eliminatethe
theuse
useor
orgeneration
generationof
ofhazardous
hazardoussubstances
substances
3’-benzoyl-4’-phenyl-5’-(piperazine-1-
ylmethyl)spiro[indoline-3,2’-pyrrolidine]-2-
one.
3’-benzoyl-4’-(p-tolyl)-5’-(piperazine-1-
ylmethyl )spiro[indoline-3,2’-pyrrolidine]-2-
one.
3’-benzoyl-4’-(4-methoxyphenyl)-5’-
(piperazine-1-ylmethyl)spiro[indoline-3,2’-
pyrrolidine]-2-one.
3’-benzoyl-4’-(4-bromophenyl)-5’-(piperazine-
1-ylmethyl)spiro[indoline-3,2’-pyrrolidine]-2-
one.
ToTo discover and
characterize effective
analyse
To carry out the
therapeutic molecu
agents lar
with
the newly synth esized
docking studies to p red ict the
minimum
copmpoun side effects
ds with and
their
predomin ant binding mod es
melting point, FT-IR, ¹H-NMR
ofmaximum potential
the ligand with protein .
and ¹³C NMR.
actions.
EXPERIMENTAL METHODS
Synthesis of 3’-benzoyl-4’-
substituted Spiranes
Mixture of isatin, 2-(piperazine-1-yl) ethanamine
Aryl substituted chalcones
Sulphated yttria as catalyst
FT-IR spectrum
FT-IR absorption bands (cm-1) of compounds
of
4’-sustituted spiranes
Carbonyl C=O
Compounds -NH
Due to benzoyl Due to indolone
group group
spiro[indoline-3,2'-pyrrolidin]-2-one
1
H chemical shifts (ppm) of compounds 4’-substituted spiranes
C-8,C-12
Compounds H-3 H-4 H-5 H-6 Aromatic protons
N-H Others
C-9,C-11
18 5.02 4.49 4.15 1.25 2.21- 2.60 0.88, 6.47, 7.95 - 6.75-7.46
19 5.03 4.47 4.10 1.28 2.25- 2.76 0.97, 6.67, 7.93 1.95 (CH3) 6.68-7.46
20 5.08 4.48 4.11 1.27 1.85 -2.37 0.89, 6.47, 7.95 4.14 (OCH3) 6.75-7.46
21 5.18 4.64 4.32 1.57 2.19- 2.87 1.43, 6.59, 8.10 - 6.75-7.45
1
H-NMR spectrum of 3'-benzoyl-4'-(p-tolyl)-5'-(piperazin-1-
ylmethyl)
spiro[indoline-3,2'-pyrrolidin]-2-one
1
H NMR spectrum of 3'-benzoyl-4'-(4-methoxyphenyl)- 5'-(piperazin-1-ylmethyl)
spiro[indoline-3,2'-pyrrolidin]-2-one
1
H- NMR spectrum of 3'-benzoyl-4'-(4-bromophenyl)-5'-(piperazin-1-ylmethyl)
spiro[indoline-3,2'-pyrrolidin]-2-one
C NMR spectrum of 3'-benzoyl-4'-phenyl- 5'- (piperazin-1-ylmethyl)
13
spiro[indoline-3,2'-pyrrolidin]-2-one
13
C chemical shifts of 4’-substituted spiranes (δ ppm)
Compounds 18 19 20 21
21.4 54.3
Others -
-
(CH3) (OCH3)
spiro[indoline-3,2'-pyrrolidin]-2-one
13
C NMR spectrum of 3'-benzoyl-4'-(4-methoxyphenyl)-5'-(piperazin-1-ylmethyl
)spiro[indoline-3,2'-pyrrolidin]-2-one
13
C NMR spectrum of 3'-benzoyl-4'-(4-bromophenyl)-5'-(piperazin-1-
ylmethyl) spiro[indoline-3,2'-pyrrolidin]-2-one
Molecular Docking Studies
Docking studies were performed to gain insight into the
protein inhibitor interactions inside the enzyme binding sites.
Molecular docking studies of all the compounds were
performed with Argus lab and the visualization is carried out
using discovery studio 4.5.
A comparative and automated docking study with newly
synthesized lead compounds was performed to determine the
best in silico conformation.
3D and 2D view of binding interaction
D and 2D view of binding interaction of standard drug 1RV1
CONCLUSION